Target intelligence / Profile preview

IQ motif and Sec7 domain-containing protein 2 (IQSEC2)

Target
IQSEC2
Molecular classification
Enzyme (specifically, guanine nucleotide exchange factor), Regulatory protein for small GTPases (Arf family), Synaptic protein
01

Overview

IQ motif and Sec7 domain-containing protein 2 (IQSEC2) is a synaptic enzyme predominantly expressed in the brain and encoded by the X-linked IQSEC2 gene. It acts as a guanine nucleotide exchange factor (GEF) specific for the ADP-ribosylation factor (Arf) family of small GTPases, most specifically Arf6. The protein contains multiple functional domains, including an IQ domain (calmodulin-binding), a Sec7 domain (catalyzes GDP-GTP exchange), a pleckstrin homology (PH) domain (guides localization and membrane interaction), a coiled-coil domain (self-association), a proline-rich domain (protein-protein interaction), and a PDZ-binding motif (linking to postsynaptic density scaffolding proteins). IQSEC2 orchestrates synaptic plasticity, dendritic spine morphogenesis, and membrane trafficking by relaying calcium-calmodulin and NMDA receptor signals to cytoskeletal reorganization and receptor dynamics. Mutations in IQSEC2 are associated with X-linked intellectual disability, epilepsy, and autism, with pathogenic variants disrupting synapse structure and function, resulting in severe developmental encephalopathies.

Other names
KIAA0522BRAG1IQ-ArfGEFBrefeldin A resistant Arf-guanine nucleotide exchange factor 1MRX1MRX18MRX78XLID1
02

Mechanism of action

Not applicable; drugs do not directly target IQSEC2. For antiepileptic treatments in patients with IQSEC2 mutations, the mechanism relates to general modulation of neuronal excitability, not direct interaction with the target.

03

Biological functions

Modulates excitatory and inhibitory synaptic transmissionRegulates dendritic spine growth and morphologyPromotes axonal elongation and branchingModulates cytoskeletal organizationRegulates membrane trafficking and receptor recyclingInfluences synaptic plasticity
04

Disease associations

Neurodevelopmental disorders (e.g., intellectual disability)Epileptic encephalopathyAutism spectrum disorderX-linked intellectual disability
05

Safety considerations

IQSEC2 is essential for normal neuronal development; loss-of-function or missense mutations can cause severe, early-onset neurological disordersTargeting or modulating IQSEC2 directly is potentially risky due to critical roles in brain development and synaptic signaling.Variability in phenotypes even among individuals with similar mutations; therapeutic interventions require precise genetic diagnosis and cautious management.
06

Interacting drugs

No specific drugs known to directly target IQSEC2 as of current clinical use or published literature. Management of associated disorders is symptomatic (e.g., antiepileptics) rather than direct modulation of IQSEC2.
07

Biomarkers

Mutations in IQSEC2 (as detected by gene sequencing) serve as diagnostic biomarkers for IQSEC2-related encephalopathy and related syndromesNo established biomarkers for therapeutic response or efficacy monitoring.

Beyond the preview

Go deeper on IQ motif and Sec7 domain-containing protein 2 (IQSEC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IQ motif and Sec7 domain-containing protein 2 (IQSEC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call